Halocare 0.25mg Tablet DT
Prescription Required
Product introduction
Halocare 0.25mg Tablet DT is used in the treatment of schizophrenia (a mental disorder in which a person develops unreal thoughts and behavior). It works by blocking the action of a chemical messenger in the brain that affects thoughts and mood.
Halocare 0.25mg Tablet DT is used to treat certain mental disorders such as schizophrenia (a mental illness which causes disturbed thinking, strong emotions and abnormal behaviour), mania (an abnormally elevated mood state), behavioural problems in adults and children and symptoms of Tourette's disease (repetative uncontrolled movements and sounds).
Halocare 0.25mg Tablet DT is used to treat certain mental disorders such as schizophrenia (a mental illness which causes disturbed thinking, strong emotions and abnormal behaviour), mania (an abnormally elevated mood state), behavioural problems in adults and children and symptoms of Tourette's disease (repetative uncontrolled movements and sounds).
Uses of Halocare Tablet DT
Benefits of Halocare Tablet DT
In Schizophrenia
Schizophrenia is a mental disorder in which a person’s thinking ability, feelings and behavior become abnormal. Halocare 0.25mg Tablet DT helps restore the chemical imbalances in the brain that are responsible for such changes. It improves thoughts, behavior and enhances the quality of life. It needs to be taken regularly to work effectively. Do not stop taking it unless your doctor advises you to.
Side effects of Halocare Tablet DT
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them
Common side effects of Halocare
- Agitation
- Extrapyramidal symptoms
- Insomnia (difficulty in sleeping)
- Muscle spasm
- Headache
How to use Halocare Tablet DT
Take this medicine in the dose and duration as advised by your doctor. Dissolve it in a glass of water before taking it. Halocare 0.25mg Tablet DT may be taken with or without food, but it is better to take it at a fixed time.
Safety advice
Alcohol
UNSAFE
Halocare 0.25mg Tablet DT may cause excessive drowsiness with alcohol.
Pregnancy
CONSULT YOUR DOCTOR
Halocare 0.25mg Tablet DT may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Breast feeding
CONSULT YOUR DOCTOR
Halocare 0.25mg Tablet DT is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
If Halocare 0.25mg Tablet DT is used, monitor the baby for excessive sleepiness.
If Halocare 0.25mg Tablet DT is used, monitor the baby for excessive sleepiness.
Driving
UNSAFE
Halocare 0.25mg Tablet DT may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Kidney
SAFE IF PRESCRIBED
Halocare 0.25mg Tablet DT is safe to use in patients with kidney disease. No dose adjustment of Halocare 0.25mg Tablet DT is recommended.
However, patients with severe kidney disease may need to be started at a lower dose as it may cause excessive sleepiness in these patients.
However, patients with severe kidney disease may need to be started at a lower dose as it may cause excessive sleepiness in these patients.
Liver
CAUTION
Halocare 0.25mg Tablet DT should be used with caution in patients with liver disease. Dose adjustment of Halocare 0.25mg Tablet DT may be needed. Please consult your doctor.
All substitutes
For informational purposes only. Consult a doctor before taking any medicines.
Halocare 0.25mg Tablet DT
₹1.1/Tablet DT
Halodias DT 0.25 Tablet
Matias Healthcare Pvt Ltd
₹1.7/tablet dt
70% costlier
Quick tips
- Halocare 0.25mg Tablet DT helps treat schizophrenia.
- It is less likely to cause weight gain as compared to other similar medicines.
- Use caution while driving or doing anything that requires concentration as Halocare 0.25mg Tablet DT may cause dizziness and sleepiness.
- Avoid drinking alcohol while taking this medicine as it can cause increased dizziness.
- Inform your doctor if you experience any abnormal movements or have difficulty controlling movements.
- It may affect how your body regulates your temperature. Avoid getting dehydrated and drink plenty of fluids.
- Your doctor may check your heart function and level of electrolytes such as sodium and magnesium before you start treatment with this medicine and regularly thereafter.
- Do not stop taking Halocare 0.25mg Tablet DT without talking to your doctor first as it may cause worsening of symptoms.
Fact Box
Chemical Class
Butyrophenone Derivative
Habit Forming
No
Therapeutic Class
NEURO CNS
Action Class
Typical Antipsychotics
Patient concerns
Want to share the information?
Disclaimer:
Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.References
- Stahl SM, editor. Haloperidol. In: Stahl's Essential Pschopharmacology: Prescriber's Guide. 5th ed. New York, New York: Cambridge University Press; 2014. pp. 291-96.
- Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 646-48.
- Chaves RG, Lamounier JA. Breastfeeding and maternal medications. Jornal de Pediatria. 2004;80(5):4-6. [Accessed 20 Mar. 2019] (online) Available from:
- Haloperidol. County Tipperary, Ireland: Pinewood Healthcare; 2007 [revised 23 Nov. 2017]. [Accessed 25 Mar. 2019] (online) Available from:
- Central Drugs Standard Control Organisation (CDSCO). [Accessed 25 Mar. 2019] (online) Available from:
Marketer details
Name: Lifecare Neuro Products Ltd
Address: 70/1 Dharampur, Sai Road, Near Export Promotion Zone Phase-II, Baddi - 173205, (Distt. Solan) Himachal Pradesh (India).
Country of origin: India
Lab tests offered by us
Related/Popular tests
MRP
₹11
Inclusive of all taxes
10.0 tablet dt in 1 strip
SOLD OUT
Notify me